[1] Lewnard JA, Reingold AL. Emerging challenges and opportunities in infectious disease epidemiology. Am J Epidemiol 2019;188(5):873 − 82. https://doi.org/10.1093/aje/kwy264CrossRef
[2] State of the World's Vaccines and Immunization. Key facts from the report World Health Organization. Indian J Med Sci 2003;57(1):39 − 41
[3] Zhai Z. An epidemiology study on the distribution of HBsAg and anti-HBs in China. Chin J Micorbiol Immunol 1986;Suppl (special issue viral hepatitis):20 − 40.
[4] Dai ZC, Qi GM. Viral hepatitis in China-seroepidemiological survey in Chinese population (part one), 1992-1995. Beijing: Scientific and Technical Documentation Press. 1997. https://book.kongfz.com/529199/4034751045/. (In Chinese). 
[5] National Administration of Disease Prevention and Control, The Minister of Health, Chinese Center for Disease Control and Prevention. Report on the seroepidemiological survey of viral hepatitis B in the national population. Beijing: People’s Medical Publishing House. 2011. https://book.kongfz.com/7277/5614717210/. (In Chinese). 
[6] National Administration of Disease Prevention and Control, Chinese Center for Disease Control and Prevention. National Seroepidemiological Survey report on viral hepatitis B in population aged 1-29 years, 2014. Beijing: People’s Medical Publishing House. 2019. https://book.kongfz.com/181694/6453682125/. (In Chinese). 
[7] Wu QS, Zaid M, Xuan ZL, Wang CX, Gu HY, Shi M, et al. Changes in epidemiological features of vaccine preventable infectious diseases among three eras of national vaccination strategies from 1953 to 2018 in Shanghai, China. Lancet Reg Health West Pac 2021;7:100092. https://doi.org/10.1016/j.lanwpc.2021.100092CrossRef
[8] Roush SW, Murphy TV, The Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA 2007;298(18):2155 − 63. https://doi.org/10.1001/jama.298.18.2155CrossRef
[9] Yang SG, Wu J, Ding C, Cui YX, Zhou YQ, Li YP, et al. Epidemiological features of and changes in incidence of infectious diseases in China in the first decade after the SARS outbreak: An observational trend study. Lancet Infect Dis 2017;17(7):716 − 25. https://doi.org/10.1016/S1473-3099(17)30227-XCrossRef
[10] Hu JY, Tao LN, Shen J, Wang YC. Study on the epidemiological characteristics of rubella from 1990-2006 in Shanghai. Chin J Epidemiol 2007;28(7):645 − 8. https://doi.org/10.3760/j.issn:0254-6450.2007.07.005CrossRef